Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3917-3928
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3917
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3917
Figure 1 Profiling of fibrosis marker genes in liver samples from patients with hepatitis B virus infection.
qPCR of fibrosis marker genes in hepatitis B virus patients with advanced fibrosis (S3-4, n = 16) compared to patients with less fibrosis (S0-1, n = 16). Values presented are expressed as the means ± SE; Statistical comparisons were made using the Mann–Whitney–Wilcoxon test; P value < 0.05 was considered significant; aP < 0.05; bP < 0.01; cP < 0.001. FAP: Fibroblast activation protein; α-SMA: Alpha-smooth muscle actin; TIMP1: Tissue inhibitor of metalloproteinase 1; COL1A1: Collagen type 1 alpha 1 chain; TLR4: Toll-like receptor 4.
- Citation: Yao QY, Feng YD, Han P, Yang F, Song GQ. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World J Gastroenterol 2020; 26(27): 3917-3928
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3917.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3917